CoChat

Endocrinology and immunology of acne: Two sides of the same coin

Zouboulis, Christos C. · 2020 · Experimental Dermatology
Cited by 66

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

Current experimental research on acne pathophysiology has revealed a more complicated background than the classically reported four‐factor aetiology. Cells of the pilosebaceous unit, which represent the template for the development of acne lesions, seem to be parallelly affected by endocrinological/metabolic factors as well as inflammatory/immunological ones that cooperate in sebocyte differentiation and lipogenesis. Indeed, the unique programme of sebocyte terminal differentiation and death, the so called holocrine secretion, is influenced by inflammatory and metabolic (lipid) signalling with common denominator the selective regulation of peroxisome proliferator‐activated receptors. Autophagy provides substrates for energy generation and biosynthesis of new cell structure proteins contributing to the normally increased sebaceous gland metabolic functions, which are also regulated by extracellular calcium signalling, essential lipids and hormones. The ultimate differentiation product of human sebocytes, sebum, co‐regulates the inflammatory sebocyte status. Sebum composition is controlled among others by Propionibacterium acnes and other bacteria, sexual hormones, neuropeptides, endogenous opioids and environmental agents, which may function as endocrine disruptors. Diet may also be an important source of substrates for the synthesis of pro‐inflammatory and anti‐inflammatory sebaceous lipids. Sebum changes might induce inflammation and initiate underlying immune mechanisms leading to acne lesions. Current new therapeutic efforts on acne concentrate on anti‐inflammatory/immunologically active concepts, which are able to regulate sebaceous lipogenesis. At last, current molecular studies based on published molecular data sets confirmed the major role of inflammation in acne development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/exd.14172

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Research works printed but not linked: 167

  1. 10.1007/s00105-009-1830-1 · DOI
  2. 10.4161/derm.1.3.8496 · DOI · Paper page
  3. 10.1159/000095058 · DOI
  4. 10.1111/bjd.15879 · DOI · Paper page
  5. 10.1007/978-3-540-69375-8_10 · DOI
  6. 10.1111/j.1600-0625.1994.tb00271.x · DOI · Paper page
  7. 10.1046/j.1523-1747.2003.12029.x · DOI
  8. 10.1016/j.jid.2016.10.017 · DOI
  9. 10.1016/j.jid.2016.12.009 · DOI
  10. Géczy T., 1988, J. Invest. Dermatol., 2012, 132
  11. 10.1111/j.1365-2133.2010.10037.x · DOI · Paper page
  12. 10.1016/j.jid.2019.06.150 · DOI
  13. 10.1111/exd.13752 · DOI
  14. 10.1016/j.jid.2018.07.015 · DOI
  15. 10.2340/00015555-2525 · DOI
  16. 10.1111/jcmm.14505 · DOI
  17. 10.4161/derm.3.1.13900 · DOI · Paper page
  18. Zouboulis C. C., 2020, The pro‐differentiation effect of doxycycline on human SZ95 sebocytes, Dermatology
  19. Stewart M. E., 1992, Semin. Dermatol., 11, 100
  20. 10.1016/S0190-9622(86)70025-X · DOI · Paper page
  21. 10.1038/2031067b0 · DOI
  22. 10.1111/bjd.14409 · DOI · Paper page
  23. 10.1038/sj.jid.5700434 · DOI · Paper page
  24. 10.1046/j.1523-1747.1999.00693.x · DOI
  25. 10.1007/s00403-008-0879-5 · DOI
  26. Angres S., 2010, Thesis
  27. 10.1111/j.1365-2133.2011.10340.x · DOI · Paper page
  28. 10.1111/exd.13855 · DOI
  29. 10.1046/j.0022-202x.2001.01612.x · DOI
  30. 10.1128/IAI.73.8.4512-4521.2005 · DOI · Paper page
  31. 10.1189/jlb.0313143 · DOI · Paper page
  32. 10.1038/s41598-018-22132-z · DOI
  33. 10.1016/j.bcp.2017.04.030 · DOI · Paper page
  34. 10.1016/j.jdermsci.2013.01.009 · DOI
  35. 10.1016/j.bbagen.2013.05.016 · DOI · Paper page
  36. 10.1016/j.jsbmb.2014.07.010 · DOI
  37. 10.1111/exd.12507 · DOI
  38. 10.1016/j.jdermsci.2014.04.008 · DOI
  39. Zhang S., 1827, Mol. Cell. Biol., 2014, 34
  40. 10.1016/j.yexcr.2014.12.004 · DOI
  41. 10.1016/j.febslet.2015.04.003 · DOI
  42. 10.1371/journal.pone.0169824 · DOI
  43. Zouboulis C. C., 2013, World Clin. Dermatol., 1, 37‐51133
  44. 10.1007/s004030050469 · DOI
  45. 10.1111/j.1346-8138.1995.tb03381.x · DOI · Paper page
  46. 10.1111/1523-1747.ep12340934 · DOI · Paper page
  47. 10.1038/sj.jid.5701155 · DOI · Paper page
  48. 10.1038/sj.jid.5700743 · DOI
  49. 10.4172/2155-9554.1000399 · doi:10.4172/2155-9554.1000399
  50. 10.1111/exd.12142 · DOI · Paper page
  51. 10.1530/JOE-14-0323 · DOI · Paper page
  52. 10.1159/000017861 · DOI · Paper page
  53. 10.1210/endo.140.9.6957 · DOI · Paper page
  54. 10.1034/j.1600-0625.2003.00014.x · DOI · Paper page
  55. 10.1016/j.exger.2008.07.005 · DOI
  56. 10.1038/jid.2013.413 · DOI
  57. 10.1111/ced.12794 · DOI · Paper page
  58. 10.1038/jid.2012.202 · DOI
  59. 10.5021/ad.2019.31.4.479 · DOI
  60. 10.14310/horm.2002.11109 · DOI · Paper page
  61. Zouboulis C. C., 2009, Neuroimmunology of the Skin – Basic Science to Clinical Practice, 219, 10.1007/978-3-540-35989-0_20 · DOI
  62. 10.1210/er.21.5.457 · DOI · Paper page
  63. 10.1001/archderm.139.7.897 · DOI · Paper page
  64. 10.1111/j.1600-0625.2004.00254.x · DOI · Paper page
  65. 10.1034/j.1600-0625.2002.110307.x · DOI · Paper page
  66. 10.1038/sj.jid.5700439 · DOI
  67. 10.1016/j.det.2007.06.001 · DOI
  68. 10.1111/j.1365-2133.2008.08959.x · DOI · Paper page
  69. 10.1046/j.0022-202x.2001.01704.x · DOI
  70. 10.1055/s-2007-961811 · DOI · Paper page
  71. 10.1073/pnas.102180999 · DOI · Paper page
  72. 10.1111/j.1600-0625.2007.00565.x · DOI · Paper page
  73. 10.1016/j.jid.2018.02.022 · DOI
  74. 10.1111/exd.13042 · DOI
  75. 10.1007/s11154-016-9371-2 · DOI · Paper page
  76. Ju Q., 2013, Biosafety, 2, 3
  77. 10.4161/derm.1.3.7862 · DOI · Paper page
  78. 10.1016/j.dsi.2012.01.007 · DOI · Paper page
  79. Ju Q., 2011, Chin. J. Dermatol., 44, 761
  80. 10.1016/j.cbi.2016.08.012 · DOI
  81. 10.1159/000491029 · DOI
  82. 10.1111/j.1600-0625.2010.01204.x · DOI · Paper page
  83. Yu Q., 2013, Chin. J. Dermatol., 46, 557
  84. 10.1093/toxsci/kfr223 · DOI · Paper page
  85. Hu T., 2014, Chin. J. Derm. Venereol., 28, 111
  86. 10.1016/j.etap.2016.02.011 · DOI
  87. 10.1016/j.freeradbiomed.2016.11.021 · DOI
  88. 10.1016/j.jaad.2009.11.021 · DOI
  89. 10.1111/1523-1747.ep12477026 · DOI
  90. 10.1111/j.1365-2133.1988.tb02566.x · DOI · Paper page
  91. 10.1111/j.0906-6705.2005.0285a.x · DOI · Paper page
  92. 10.1159/000382031 · DOI
  93. 10.1016/j.devcel.2019.08.015 · DOI
  94. 10.1016/j.cell.2018.12.031 · DOI · Paper page
  95. 10.1517/14656566.2011.553192 · DOI
  96. 10.1111/j.1365-2133.2012.10897.x · DOI · Paper page
  97. 10.1016/j.jdermsci.2012.03.004 · DOI
  98. 10.4049/jimmunol.1800893 · DOI · Paper page
  99. 10.3389/fmed.2019.00155 · DOI · Paper page
  100. 10.1002/pmic.200800044 · DOI · Paper page
  101. 10.1016/j.bbrc.2013.07.129 · DOI
  102. 10.1111/j.1600-0625.2006.00458.x · DOI · Paper page
  103. 10.1038/sj.jid.5700028 · DOI
  104. 10.1016/j.lfs.2015.07.028 · DOI
  105. 10.1007/s00105-012-2457-1 · DOI
  106. 10.1038/jid.2014.221 · DOI
  107. 10.1016/j.jdermsci.2011.11.005 · DOI
  108. 10.1002/ptr.6195 · DOI · Paper page
  109. 10.1038/jid.2015.151 · DOI
  110. 10.1111/exd.12867 · DOI
  111. 10.1007/s00403-015-1565-z · DOI
  112. 10.1038/jid.2009.190 · DOI
  113. 10.1038/jid.2009.46 · DOI
  114. 10.4014/jmb.1005.05025 · DOI
  115. 10.1016/j.jdermsci.2013.10.010 · DOI · Paper page
  116. Lee D.‐Y., 1863, J. Invest. Dermatol., 2008, 128
  117. 10.1073/pnas.121574098 · DOI · Paper page
  118. 10.1371/journal.pone.0198323 · DOI
  119. 10.1080/19381980.2017.1338993 · DOI
  120. 10.1586/17469872.2.6.693 · DOI
  121. 10.1111/bjd.13639 · DOI
  122. Dessinioti C., 2020, J. Eur. Acad. Dermatol. Venereol.
  123. 10.1038/sj.jid.5700418 · DOI
  124. 10.1038/jid.2008.338 · DOI
  125. 10.1038/sj.jid.5700289 · DOI · Paper page
  126. 10.1007/BF02505275 · DOI
  127. 10.1111/bjd.18562 · DOI
  128. 10.1111/j.0022-202X.2005.23848.x · DOI
  129. 10.1038/jid.2012.111 · DOI · Paper page
  130. 10.1172/JCI33869 · DOI · Paper page
  131. 10.1093/ajcn/83.2.191 · DOI · Paper page
  132. 10.3181/0706-MR-158 · DOI · Paper page
  133. 10.1176/appi.ajp.162.5.983 · DOI · Paper page
  134. 10.3181/0703-RM-83 · DOI
  135. 10.1159/000182270 · doi:10.1159/000182270
  136. 10.1111/j.1468-3083.2010.03933.x · DOI · Paper page
  137. 10.1111/j.1600-0625.2010.01107.x · DOI · Paper page
  138. 10.1111/jdv.16252 · DOI · Paper page
  139. Choi K. O., 2020, Dermatology
  140. Markovics A., 2020, J. Invest. Dermatol.
  141. 10.1159/000400356 · doi:10.1159/000400356
  142. Mastrofrancesco A., 1903, J. Immunol., 2010, 185
  143. 10.1111/j.1468-3083.2012.04658.x · DOI
  144. 10.1016/j.ejphar.2010.10.100 · DOI
  145. 10.1016/S0092-8674(00)80467-5 · DOI · Paper page
  146. 10.1055/s-2003-43493 · DOI
  147. 10.1111/j.1600-0625.2009.00929.x · DOI · Paper page
  148. 10.1001/archderm.139.5.668 · DOI
  149. 10.1159/000081481 · DOI · Paper page
  150. 10.4161/derm.1.3.8368 · DOI · Paper page
  151. 10.1371/journal.pone.0001551 · DOI · Paper page
  152. 10.1016/j.jid.2018.05.032 · DOI · Paper page
  153. 10.1038/jid.2008.117 · DOI
  154. 10.1002/ptr.6304 · DOI
  155. 10.1016/j.pdpdt.2017.03.006 · DOI
  156. 10.1016/j.pdpdt.2018.06.024 · DOI
  157. 10.1159/000489396 · DOI
  158. 10.1038/jid.2015.29 · DOI
  159. 10.3892/ijmm.2015.2098 · DOI
  160. 10.1159/000439378 · DOI
  161. Zampeli V. A., 1898, Curr. Pharm. Biotechnol., 2012, 13
  162. 10.1016/j.jaad.2016.08.053 · DOI
  163. Hebert A., 2020, JAMA Dermatol., e200465
  164. 10.1016/j.jaad.2020.04.087 · DOI
  165. 10.1080/13543784.2017.1337745 · DOI
  166. Chen B., 2019, BioMed. Res. Int., 2019, 3739086
  167. 10.1159/000502203 · DOI

Cited by

Metadata

Authors
Zouboulis, C. C.
Venue
Experimental Dermatology
Publisher
Wiley
Published
2020-09
Volume
29
Issue
9
Pages
840-859
ISSN
  • 0906-6705
  • 1600-0625
Cited by
66
References
36
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.